Treatment of bone and joint infections by ceftazidime/avibactam and ceftolozane/tazobactam: a cohort study

Treatment of bone and joint infections by ceftazidime/avibactam and ceftolozane/tazobactam: a cohort study

ABSTRACT: Objectives: Ceftazidime/avibactam (C/A) and ceftolozane/tazobactam (C/T) are two novel antibacterials with known efficacy against Gram-negative bacteria (GNB). We aimed to describe the efficacy and safety of surgical management combined with C/A or C/T treatment for bone and joint infecti...

Full description

Bibliographic Details
Main Authors: Claire Rempenault, Valentine Pagis, Latifa Noussair, Simona Berbescu, Clara Duran, Frédérique Bouchand, Marine de Laroche, Elsa Salomon, Christophe Nich, Thomas Bauer, Martin Rottman, Benjamin Davido, Morgan Matt, Aurélien Dinh
Format: Article
Language:English
Published: Elsevier 2021-06-01
Series:Journal of Global Antimicrobial Resistance
Subjects:
Multidrug resistance
Bone and joint infection
BJI
Ceftazidime/avibactam
Ceftolozane/tazobactam
Resistance
Online Access:http://www.sciencedirect.com/science/article/pii/S2213716521000941

Internet

http://www.sciencedirect.com/science/article/pii/S2213716521000941

Similar Items